Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quality assurance operations: good clinical practices.

A W Castellion

    Drug Information Journal
    |December 12, 1982
    PubMed
    Summary

    Pharmaceutical sponsors ensure clinical data quality for New Drug Applications (NDAs) through a systematic quality assurance approach. This involves robust procedures, organizational oversight, and data assessment to guarantee reliable research findings.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    International regulatory aspects of clinical periodontal research.

    Annals of periodontology·1997
    Same author

    Preclinical pharmacology of saralasin.

    Kidney international. Supplement·1979
    Same author

    Prevention by bismuth subsalicylate of gastric mucosal lesions in response to noxious stimuli in rats.

    Pharmacological research communications·1978
    Same author

    The antidiarrheal action of bismuth subsalicylate in the mouse and the rat.

    The American journal of digestive diseases·1975
    Same author

    Protective effect of Pepto-Bismol liquid on the gastric mucosa of rats.

    Gastroenterology·1975
    Same author

    Dantrolene, a direct acting skeletal muscle relaxant.

    Journal of pharmaceutical sciences·1973

    Area of Science:

    • Pharmaceutical research
    • Clinical trial data management
    • Regulatory affairs

    Background:

    • The pharmaceutical industry sponsor is responsible for verifying clinical data for New Drug Applications (NDAs).
    • Ensuring the integrity of clinical trial data is paramount for regulatory approval.
    • Human trials with research compounds generate vast amounts of data requiring rigorous quality control.

    Purpose of the Study:

    • To outline a systematic approach for quality assurance in clinical data.
    • To detail essential components for ensuring the reliability of data from human trials.
    • To emphasize preventive strategies for maintaining high-quality research data.

    Main Methods:

    • Implementing Standard Operating Procedures Manuals.
    • Establishing an internal quality assurance function.
    • Maintaining detailed documentation of all monitoring activities.
    • Conducting careful assessment of all collected clinical research data.
    • Focusing on preventive measures for future data quality.

    Main Results:

    • A structured quality assurance framework enhances clinical data integrity.
    • Systematic approaches reduce errors and improve data reliability.
    • Preventive measures are key to ensuring the quality of subsequent research data.

    Conclusions:

    • A comprehensive quality assurance system is essential for pharmaceutical sponsors.
    • Robust data verification processes support successful New Drug Applications.
    • Continuous improvement through preventive measures ensures long-term data quality and regulatory compliance.

    Related Experiment Videos